Clinical Research, Pharma & Healthcare FinancingVertex Announces CASGEVY® Reimbursement for SCD in EnglandBusiness WireJanuary 31, 2025February 12, 2025 by Business WireJanuary 31, 2025February 12, 202506 – Agreement means eligible sickle cell disease (SCD) patients in England now have access to CASGEVY – – Agreement for CASGEVY in transfusion-dependent beta thalassemia...
